Home 5 Articles 5 Revised VALID Act Proposes Risk-Based FDA Regulation of LDTs

Revised VALID Act Proposes Risk-Based FDA Regulation of LDTs

by | Jun 8, 2022

The most recent congressional effort to pass LDT legislation may prove to be the one that finally comes to fruition.

The most recent congressional effort to pass LDT legislation may prove to be the one that finally comes to fruition.

This content is Exclusive to National Lab Reporter Subscribers

Subscribe or Log in for Exclusive Access.